Sotyktu (Deucravacitinib) is a prescription medication used to treat moderate to severe plaque psoriasis in adults for whom systemic therapy or phototherapy is considered appropriate. Plaque psoriasis is an autoimmune condition that causes inflamed skin patches called plaques on the body. Plaques can cause pain, itching, and bleeding. The active ingredient in Sotyktu is Deucravacitinib. Deucravacitinib belongs to a class of medications called kinase inhibitors. It works by blocking a protein called tyrosine kinase 2 to reduce the severity and amount of psoriasis lesions.
Manufacturer Information
We currently offer the brand Sotyktu from Canada manufactured by Bristol-Myers Squibb in the strength of 6mg tablets. The generic Deucravacitinib is not available.
Get medical help immediately if you have any of these signs or an allergic reaction while using Sotyktu. The most common side effects of Sotyktu may include the following:
• Mouth sores;
• Small red bumps on the skin (folliculitis)
Contact your doctor right away if you have any of the severe side effects, including:
• Chest tightness;
• Feeling faint;
• Signs of an allergic reaction, such as trouble breathing, hives, swelling of the face, lips, or throat;
• Signs of an infection such as persistent sore throat, fever, chills, cough;
• Signs of muscle problems such as fatigue, unexplained muscle pain, fever, dark-colored urine;
• Unexplained weight loss
These are not all of the side effects of Sotyktu. Always contact your doctor if you notice any unusual symptoms.
You should not use Sotyktu if you are allergic to Deucravacitinib or any ingredient in Sotyktu. Before you start using this medication, tell your doctor about your medical history, especially if you:
• Are breastfeeding or planning to breastfeed;
• Are pregnant or planning to become pregnant;
• Have a history of infections such as tuberculosis, HIV, or herpes;
• Have a recurrent infection;
• Have cancer;
• Have high levels of fats in the blood;
• Have lactose intolerance;
• Have liver disease;
• Have recently received or are scheduled to receive an immunization
Tell your doctor about all your medications, including prescription, OTC, herbal supplements, and vitamins. There may be drug interactions between Sotyktu and other medicines, like prednisone, otezla, skyrizir, etc. Tell your doctor if you are pregnant or planning to become pregnant. It is unknown if Sotyktu can harm your fetus. This drug should only be used in pregnancy if the benefits outweigh the risks. Inform your doctor if you are breastfeeding or planning to breastfeed. It is unknown if Deucravacitinib passes into breast milk or if it may harm your nursing infant. Use this medicine exactly as your doctor prescribes. Sotyktu is a tablet. Swallow the tablet whole. Do not break, crush, or chew them. Take your drug once a day. You can take the drug at the same time every day to help you remember. If you miss a dose, skip the missed dose and continue with your regular dosing schedule. You may take this drug with or without food. This drug may reduce your ability to fight infections. Avoid anyone with a contagious infection, such as chickenpox, measles, or COVID-19. Inform your doctor if you have been exposed to an infection. Store this drug at room temperature, away from light and moisture. Keep out of the reach of children.